Search results

Selected filters:

Law & Policy

Article type

Topic

Sector

Regions

2,370 results found for your search

Sort options
01 March 2019

Have your say on how the global IP market is developing

Our annual benchmarking surveys – one for IP owners and one for private practice lawyers and attorneys – open today, focusing on issues such as licensing, valuation, patent office performance and the best litigation venues

27 February 2019

The search to find 2019’s entrants into the IP Hall of Fame continues

Your chance to nominate someone to join last year’s inductees Richard Linn, Ella Cheong and Kevin Rhodes in the pantheon of all-time greats

26 February 2019

Two years of trade war spotlight have done little to change views of IP environment in China

But American Chamber of Commerce in China survey does reveal that IP concerns are affecting US firms' business plans, and ‘cautious pessimism’ is the new normal

25 February 2019

Stockpiling of SPC-protected drugs by generics set to be allowed in the EU<strong> </strong>

Legislative disputes over the nature of a proposed manufacturing waiver have been resolved paving the way for implementation of controversial new regime

25 February 2019

China mulls ‘open licensing’ option that may not have many takers

Amendments to China’s Patent Law will likely offer firms an option to open their portfolios to all willing royalty-payers, but it may not provide enough incentive to attract users

22 February 2019

Japanese industry, government divided on patent reforms

Japan Inc is not on board with the JPO’s plans to boost damages and bring in new discovery procedures

21 February 2019

Startups from Southeast Asia have little to fear from IP but much to gain

At IPBC Southeast Asia, members of the region’s dynamic startup ecosystem heard that while IP may not yet be a critical threat to their business, it presents unique opportunities

18 February 2019

Rolling the dice on eligibility

Congressional action is the only way to solve the uncertainty on section 101 of the US patent statute, argues Aaric Eisenstein of Personalised Media Communications

14 February 2019

As 101 debate continues, Iancu offers clear message to Federal Circuit

With new guidelines set to reshape patent examination, the USPTO head makes the case for revisiting subject matter precedent

13 February 2019

IPBC Global 2019 is shaping up to be the biggest and best of the series so far

Senior decision makers from a wide range of companies are already confirmed to attend as demand for tickets exceeds the rate for last year's sell-out event in San Francisco 

11 February 2019

Huawei owns the future and that’s why it’s here to stay

Deep pockets, a strong commitment to R&D and a world class 5G patent portfolio mean that whatever its current difficulties the Chinese telecoms business is set to be a major player for the long term

09 February 2019

The big life sciences patent developments in January

Record-breaking Celgene purchase, two decisions on the on-sale bar, Europe moves towards SPC manufacturing waiver, China proposes five-year patent term extension and much more

08 February 2019

US patent system jumps to second in the world, though the biopharma sector may not agree

PTAB reforms help fuel a miraculous rise up the latest International IP Index, but a recent Federal Circuit decision on eligibility highlights the serious challenges that remain - especially for life sciences companies

05 February 2019

USPTO rules on patent term adjustment set to change following CAFC decision

The Federal Circuit’s precedential judgment in Supernus Pharmaceuticals v Iancu is good news for rights holders – especially those in life sciences

01 February 2019

We have not been informed of any Chinese antitrust investigation of us, Ericsson tells <em>IAM</em>

Swedish company issues statement after an unsourced Chinese media article claims that a probe into its licensing practices is underway